Breast cancer in young women after treatment for Hodgkin's disease during childhood or adolescence: An observational study with up to 33-year follow-up;Brustkrebs bei jungen frauen nach therapie eines Hodgkin-lymphoms im kindes- und jugendalter: Eine beobachtungsstudie mit bis zu 33 jahren follow-up

Deutsches Arzteblatt International

Volumn 111, Issue 1-2, 2014, Pages 3-9

  Schellong, Günther ^a   Riepenhausen, Marianne ^a   Ehlert, Karoline ^a   Brämswig, Jürgen ^a   Wolfgang, Dörffel ^b   Schmutzler, Rita K ^c   Rhiem, Kerstin ^c   Bick, Ulrich ^d  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b HELIOS KLINIKUM BERLIN BUCH   (Germany)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER PATIENT; CHILDHOOD DISEASE; FOLLOW UP; HODGKIN DISEASE; HUMAN; RADIATION DOSE; ADOLESCENT; ADULT; BREAST NEOPLASMS; CHILD; COMORBIDITY; EPIDEMIOLOGY; FEMALE; GERMANY; INCIDENCE; LONGITUDINAL STUDY; MIDDLE AGED; MORTALITY; PRESCHOOL CHILD; RADIOTHERAPY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE;

ADOLESCENT; ADULT; BREAST NEOPLASMS; CAUSALITY; CHILD; CHILD, PRESCHOOL; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; GERMANY; HODGKIN DISEASE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MIDDLE AGED; RADIOTHERAPY; RISK FACTORS; SURVIVAL RATE;

EID: 84893328127     PISSN: 18660452     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2014.0003     Document Type: Article

References (38)

1. Hancock SL, Tucker MA, Hoppe RT: Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 1993; 85: 25-31. (Pubitemid 23023219)
2. Bhatia S, Robison LL, Oberlin O, et al.: Breast cancer and other second neoplasms after childhood Hodgkin's disease. New Engl J Med 1996; 334: 745-51 (Pubitemid 26089355)
3. Sankila R, Garwicz S, Olsen JH, et al.: Risk of subsequent malignant neoplasms among 1641 Hodgkin's disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five Nordic countries. J Clin Oncol 1996; 14: 1442-6. (Pubitemid 26134199)
4. Bhatia S, Yasni Y, Robison LL, et al.: High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease; Report from the Late Effects Study Group. J Clin Oncol 2003; 21: 4386-94. (Pubitemid 46621816)
5. Travis LB, Hill DA, Dores GM, et al.: Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 2003; 290: 465-75. (Pubitemid 37430500)
6. Kenney LB, Yasui Y, Inskip PD, et al.: Breast cancer after childhood cancer: A report from the Childhood Cancer Survivor Study. Ann Intern Med 2004; 141: 590-7. (Pubitemid 39390536)
7. Basu SK, Schwarz C, Fisher SG, et al.: Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease. Int J Radiation Oncol Biol Phys 2008; 72: 34-40.
8. Inskip PD, Robison LL, Stovall M, et al.: Radiation dose and breast cancer risk in the Childhood Cancer Survivor Study. J Clin Oncol 2009; 27: 3901-7.
9. Alm El-Din MA, Hughes KS, Finkelstein DM, et al.: Breast cancer after treatment of Hodgkin's lymphoma: Risk factors that really matter. Int J Radiation Oncol Biol Phys 2009; 73: 69-74.
10. O'Brien MM, Donaldson SS, Balise RR, Whittemore AS, Link MP: Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy. J Clin Oncol 2010; 28: 1232-9.
11. Moskowitz CS, Chou JF, Wolden SL, et al.: New insights into the risk of breast cancer in childhood cancer survivors treated with chest radiation: A report from the Childhood Cancer Survivor Study (CCSS) and the Women's Environmental Cancer and Radiation Epidemiology (WECARE) Study. J Clin Oncol 2012; 30: CRA9513.
12. Swerdlow AJ, Cooke R, Bates A, et al.: Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin's lymphoma in England and Wales: A national cohort study. J Clin Oncol 2012; 30: 2745-52.
13. Oeffinger KC, Ford JS, Moskowitz CS, et al.: Breast cancer surveillance practices among women previously treated with chest radiation for a childhood cancer. JAMA 2009; 301: 404-14.
14. Howell SJ, Searle C, Goode V, et al.: The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage. Br J Cancer 2009; 101: 582-8.
15. Terenziani M, Casalini P, Scaperrotta G, et al.: Occurrence of breast cancer after chest wall irradiation for pediatric cancer, as detected by a multimodal screening program. J Radiation Oncol Biol Phys 2013; 85: 35-9.
16. Colin C, de Vathaire F, Noël A, et al.: Updated Relevance of Mammographic Screening Modalities in Women Previously Treated with Chest Irradiation for Hodgkin Disease. Radiology 2012; 265: 669-76.
17. Schellong G, Riepenhausen M: Late effects after therapy of Hodgkin's disease: Update 2003/04 on overwhelming post-splenectomy infections and secondary malignancies. Klin Pädiatr 2004; 216: 364-9. (Pubitemid 39524571)
18. Bramswig JH, Hörnig-Franz I, Riepenhausen M, et al.: The challenge of pediatric Hodgkin's disease: Where is the balance between cure and long-term toxicity? A report of the West German multicenter studies DAL-HD-78, DAL-HD-82 and DAL-HD-85. Leuk Lymphoma 1990; 3: 183-93.
19. Schellong G, Hörnig-Franz I, Rath B, et al.: Reducing radiation dosage to 20-30 Gy in combined chemo-/radiotherapy of Hodgkin's disease in childhood. A report of the cooperative DAL-HD-87 therapy study. Klin Pädiatr 1994; 206: 253-62.
20. Schellong G, Potter R, Bramswig JH, et al.: High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: The German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group. J Clin Oncol 1999; 17: 3736-44.
21. Bramswig JH, Heimes U, Heiermann E, et al.: The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin's disease during childhood or adolescence. Cancer 1990; 65: 1298-302. (Pubitemid 20097151)
22. Schellong G, Riepenhausen M, Creutzig U, et al.: Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. J Clin Oncol 1997; 15: 2247-53. (Pubitemid 27251125)
23. Schellong G, Riepenhausen M, Bruch C, et al.: Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: Report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD Studies. Pediatr Blood Cancer 2010; 55: 1145-52.
24. Dörffel W, Riepenhausen M, Ludwig WD, Schellong G: Langzeitfolgen nach Therapie eines Hodgkin-Lymphoms bei Kindern und Jugendlichen. Journal Onkologie 2010; 09: 449-56.
25. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
26. Gooley TA, Leisenring W, Crowley J, et al.: Estimation of failure probabilities in the presence of competing risks: New representations of old estimators. Stat Med 1999; 18: 695-706. (Pubitemid 29126745)
27. Yasui Y, Liu Y, Neglia JP, et al.: A methodological issue in the analysis of second-primary cancer incidence in long-term survivors of childhood cancers. Am J Epidemiol 2003; 158: 1108-13. (Pubitemid 37475095)
28. Antoniou AC, Cunningham AP, Peto J, et al.: The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer 2008, 98: 1457-66. (Pubitemid 351543573)
29. Schmutzler RK, Rhiem K, Breuer P, et al.: Outcome of a structured surveillance programme in women with a familial predisposition for breast cancer. Eur J Cancer Prev 2006; 15: 483-9. (Pubitemid 44757818)
30. Meindl A, Ditsch N, Kast K, Rhiem K, Schmutzler RK: Hereditary breast and ovarian cancer - new genes, new treatments, new concepts. Dtsch Arztebl Int 2011; 108(19): 323-30.
31. Largo RH, Prader A: Pubertal development in Swiss girls. Helv Paediatr Acta 1983; 38: 229-43. (Pubitemid 13038887)
32. Brämswig JH, Dübbers A: Disorders of pubertal development. Dtsch Arztebl Int 2009; 106(17): 295-304.
33. Demoor-Goldschmidt C, Supiot S, Mahé MA: Breast cancer after radiotherapy: risk factors and suggestion for breast delineation as an organ at risk in the prepuberal girl. Cancer Radiother 2012; 16: 140-51.
34. Henderson TO, Amsterdam A, Bhatia S, et al.: Systematic Review: Surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer. Ann Intern Med 2010; 152: 444-55.
35. van Leeuwen FE, Klokman WJ, Stovall M, et al.: Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst 2003; 95: 971-80. (Pubitemid 36896714)
36. Rössig C, Jürgens H, Schrappe M, et al.: Effective Childhood Cancer Treatment: The Impact of Large Scale Clinical Trials in Germany and Austria. Pediatr Blood Cancer 2013; 60: 1574-81.
37. Dörffel W, Rühl U, Lüders H, et al.: Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: Final results of the multinational trial GPOH-HD95. J Clin Oncol 2013; 31: 1562-8.
38. Mauz-Körholz C, Hasenclever D, Dörffel W, et al.: Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric hodgkin's lymphoma: The GPOH-HD-2002 Study. J Clin Oncol 2010; 28: 3680-6.